Posted 18th November 2019 by Liv Sewell
Digital pathology is transforming possibilities for patient care and the nature of pathologists’ work. But it is clear that in low-income countries, access to pathology and laboratory medicine (PALM) services is very restricted and under-developed. Low-income countries bear a disproportionate share of the global disease burden, yet they are so under-resourced in the pathology and laboratory services that are vital for the accurate diagnosis and treatment of disease. This presents a huge issue for global health.
Given this global context, Rebecca Calder, Daniel Stevens and Zev Leifer’s poster, presented at the 5th Digital Pathology and AI Congress, is of notable significance.
Posted 4th September 2019 by Liv Sewell
Most students and clinicians learn microbiology with the proper equipment: microscopes. However, in deprived countries front-line health facilities have to refer patients elsewhere because they do not have a microscope to enable diagnosis. Research is inhibited because of lack of equipment, students never get the opportunity to use real microscopes during their studies, and participation in science and particularly microbiology is very low.
Posted 19th June 2017 by Jane Williams
Anyone reading this would be familiar that in April the FDA determined after an extensive clinical trial that a whole slide imaging system presents no greater risk to patient care than an optical microscope. In a purely scientific study design, there is a null hypothesis that states “there is no significant difference between…” and then investigators try to prove or disprove that hypothesis.